To dispel the impact of cholestasis and/or liver congestion, or the potential impact of autoimmune liver disease on the diagnostic accuracy of LSM for fibrosis, we also did sensitive analyses after excluding patients with abnormal bilirubin as well as transaminase levels (including ALT, AST, and GGT). This evidence concerns the gene GPT and fibrosis.